HPV vaccine cuts cancer risk in men by half, study finds

A landmark study in JAMA Oncology reveals the HPV vaccine reduces related cancer risks in males by nearly 50%. While historically linked to cervical health, the shot effectively prevents anal, throat, and penile cancers. Experts urge universal vaccination for boys aged 9 to 12, noting that early immunisation provides robust, long-term protection against these life-threatening diseases.